Fingerprint
Dive into the research topics where Line Hammer Dohn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
ctDNA-Guided Immunotherapy following Radical Cystectomy for Muscle-Invasive Bladder Cancer: Results from the TOMBOLA Trial
Dyrskjøt, L., Birkenkamp-Demtröder, K., Nordentoft, I., Strandgaard, T., Lindskrog, S. V., Milling, R. V., Körner, S. K., Brandt, S. B., Knudsen, M., Andreasen, T. G., Hansen, C. F., Lamy, P., Lam, G., Dohn, L. H., Fabrin, K., Carus, A., Petersen, A. C., Joensen, U. N., Pappot, H. & Holt, P. S. & 3 others, , 14 Jan 2026, (E-pub ahead of print) In: Annals of Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
3 Citations (Scopus) -
Tumour microenvironment analysis by spatial transcriptomics in muscle-invasive bladder cancer to delineate therapy response biology: Results from the TOMBOLA trial
Kohler, J., Strandgaard, T., Divita, T. J., Andreasen, T. G., Lindskrog, S. V., Nordentoft, I., Lam, G. W., Dohn, L. H., Fabrin, K., Carus, A., Petersen, A., Joensen, U. N., Pappot, H., Holt, P., Jensen, N. V., Nuhn, P., Agerbæk, M., Bjerggaard Jensen, J. & Dyrskjøt, L., 14 Mar 2026.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
Comparison of ctDNA detection methods for monitoring minimal residual disease in patients with bladder cancer: Insights from the TOMBOLA trial
Nordentoft, I., Birkenkamp-Demtröder, K., Lindskrog, S. V., Strandgaard, T., Milling , R. V., Körner , S. K., Brandt, S. B., Cohen, Y., Lauterman, T., Lam, G. W., Dohn, L. H., Fabrin, K., Carus, A., Petersen, A., Joensen, U. N., Pappot, H., Holt, P. S., Jensen, N. V., Katz-zov, T. & Afterman, D. & 2 others, , 23 Mar 2025.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
ctDNA-guided immunotherapy following cystectomy in patients with urothelial carcinoma: Preliminary results from the TOMBOLA trial
Dyrskjøt, L., Birkenkamp-Demtroder, K., Nordentoft, I., Lindskrog, S. V., Strandgaard, T., Milling , R. V., Korsgaard Körner , S., Brandt, S. B., Knudsen, M., T, A., Lam, G., Dohn, L. H., Fabrin, K., Carus, A., Petersen, A., Joensen, U. N., Pappot, H., Holt, P. S., Jensen, N. V. & Agerbæk, M. & 1 others, , 23 Mar 2025.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
Assessing expression patterns of PTGR1, a potential biomarker for acylfulven sensitivity in urothelial carcinoma
Stormoen, D. R., Lehn, S., Mouw, K. W., Szallasi, Z., Melchior, L. C., Dohn, L. H., Börcsok, J., Rossing, M., Toft, B. G. & Pappot, H., 10 Nov 2024, In: Scientific Reports. 14, 1, 27448.Research output: Contribution to journal › Journal article › Research › peer-review